Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 4731891, 9 pages
https://doi.org/10.1155/2017/4731891
Research Article

Predictive Value of MiR-219-1, MiR-938, MiR-34b/c, and MiR-218 Polymorphisms for Gastric Cancer Susceptibility and Prognosis

1Division of Clinical Research, First Hospital of Jilin University, Changchun, Jilin Province 130021, China
2Maternal and Child Health Center of Chaoyang District, Beijing 100020, China
3Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun 130021, China

Correspondence should be addressed to Xueyuan Cao; moc.nuyila@yxoac and Jing Jiang; nc.ude.ulj@00020791gnijgnaij

Received 7 November 2016; Revised 28 December 2016; Accepted 16 January 2017; Published 19 February 2017

Academic Editor: Marco E. M. Peluso

Copyright © 2017 Yanhua Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. K. Leung, M.-S. Wu, Y. Kakugawa et al., “Screening for gastric cancer in Asia: current evidence and practice,” The Lancet Oncology, vol. 9, no. 3, pp. 279–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Van Cutsem, X. Sagaert, B. Topal, K. Haustermans, and H. Prenen, “Gastric cancer,” The Lancet, vol. 388, no. 10060, pp. 2654–2664, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. W. Kong, D. Ferland-McCollough, T. J. Jackson, and M. Bushell, “MicroRNAs in cancer management,” The Lancet Oncology, vol. 13, no. 6, pp. e249–e258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. K. K. Banaudha and M. Verma, “The role of MicroRNAs in the management of liver cancer,” Methods in Molecular Biology, vol. 863, pp. 241–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Dalmay and D. R. Edwards, “MicroRNAs and the hallmarks of cancer,” Oncogene, vol. 25, no. 46, pp. 6170–6175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Schetter, S. Y. Leung, J. J. Sohn et al., “MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma,” JAMA, vol. 299, no. 4, pp. 425–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Pardini, F. Rosa, E. Barone et al., “Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: a potential modulation of microRNAs binding,” Clinical Cancer Research, vol. 19, no. 21, pp. 6044–6056, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Naccarati, B. Pardini, L. Stefano et al., “Polymorphisms in mirna-binding sites of nucleotide excision repair genes and colorectal cancer risk,” Carcinogenesis, vol. 33, no. 7, pp. 1346–1351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Jiang, Z. F. Jia, D. H. Cao, Y. H. Wu, Z. W. Sun, and X. Y. Cao, “Association of the miR-146a rs2910164 polymorphism with gastric cancer susceptibility and prognosis,” Future Oncology, vol. 12, no. 19, pp. 2215–2226, 2016. View at Google Scholar
  11. B. M. Ryan, A. I. Robles, and C. C. Harris, “Genetic variation in microRNA networks: the implications for cancer research,” Nature Reviews Cancer, vol. 10, no. 6, pp. 389–402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Berezikov, V. Guryev, J. Van De Belt, E. Wienholds, R. H. A. Plasterk, and E. Cuppen, “Phylogenetic shadowing and computational identification of human microRNA genes,” Cell, vol. 120, no. 1, pp. 21–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Q. Xu, Y.-F. Wu, Y. Li et al., “SNP-SNP interactions of three new pri-miRNAs with the target gene PGC and multidimensional analysis of H. pylori in the gastric cancer/atrophic gastritis risk in a Chinese population,” Oncotarget, vol. 7, no. 17, pp. 23700–23714, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Cai, Y. Zhang, Y. Ma et al., “Association between microRNA-499 polymorphism and gastric cancer risk in Chinese population,” Bulletin du Cancer, vol. 102, no. 12, pp. 973–978, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Arisawa, T. Tahara, H. Shiroeda et al., “Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3′-UTR, influence susceptibility to gastric cancer,” Human Immunology, vol. 73, no. 7, pp. 747–752, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sanaei, M. Hashemi, M. Rezaei, S. M. Hashemi, G. Bahari, and S. Ghavami, “Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk,” Biomedical Reports, vol. 5, no. 1, pp. 125–129, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Yuan, R. Sun, P. Chen et al., “Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk,” Tumor Biology, vol. 37, no. 5, pp. 6267–6273, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Pardini, F. Rosa, A. Naccarati et al., “Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients,” Carcinogenesis, vol. 36, no. 1, pp. 82–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Zhao and R. Wang, “Quantitative assessment of pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population,” OncoTargets and Therapy, vol. 8, pp. 1859–1862, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. L. Abba, N. Patil, J. H. Leupold et al., “MicroRNAs as novel targets and tools in cancer therapy,” Cancer Letters, vol. 387, pp. 84–94, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Garzon, G. Marcucci, and C. M. Croce, “Targeting microRNAs in cancer: rationale, strategies and challenges,” Nature Reviews Drug Discovery, vol. 9, no. 10, pp. 775–789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. X. P. Ma, T. Zhang, B. Peng, L. Yu, and D. K. Jiang, “Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies,” PLoS ONE, vol. 8, no. 11, Article ID e79584, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Song, W. You, J. Zhu et al., “A genetic variant in miRNA-219-1 is associated with risk of esophageal squamous cell carcinoma in chinese kazakhs,” Disease Markers, vol. 2015, Article ID 541531, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Gao, Y. Liu, G.-L. Liu et al., “Association between the pre-mir-218 polymorphism and cancer risk in the Chinese population: a meta-analysis,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 6, pp. 2517–2522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Jiang, C. Wang, C. Sun et al., “The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 9, pp. 6206–6212, 2014. View at Google Scholar · View at Scopus
  26. H. Dweep and N. Gretz, “MiRWalk2.0: a comprehensive atlas of microRNA-target interactions,” Nature Methods, vol. 12, no. 8, p. 697, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Yamamoto, T. Kinoshita, N. Nohata et al., “Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma,” International Journal of Oncology, vol. 42, no. 5, pp. 1523–1532, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Kinoshita, T. Hanazawa, N. Nohata et al., “Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma,” Oncotarget, vol. 3, no. 11, pp. 1386–1400, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. X. He, Y. Dong, C. W. Wu et al., “MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene,” Molecular Medicine, vol. 18, no. 12, pp. 1491–1498, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. X. X. Wang, S. J. Ge, X. L. Wang, L. X. Jiang, M. F. Sheng, and J. J. Ma, “miR-218 tissue expression level is associated with aggressive progression of gastric cancer,” Genetics and Molecular Research, vol. 15, no. 2, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Tie, Y. Pan, L. Zhao et al., “MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the robo1 receptor,” PLoS Genetics, vol. 6, no. 3, Article ID e1000879, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. T.-Y. Shi, X.-J. Chen, M.-L. Zhu et al., “A pri-miR-218 variant and risk of cervical carcinoma in Chinese women,” BMC Cancer, vol. 13, article 19, 2013. View at Publisher · View at Google Scholar · View at Scopus